Kyung Hee University
Also known as: 892 Dongnam-ro, Gangdong-gu, Seoul, Korea | 892 Dongnam-ro, Gangdong-gu, Seoul, Korea. Kyung Hee University Hospital at Gangdong | Chong-Jin Kim | Department of Internal Medicine, College of Oriental Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Republic of Korea | Department of Oriental Rehabilitation Medicine/College of Oriental Medicine/Kyung Hee University | Dept. of ophthalmology, KyungHee Medical Center | Dept. ophthalmology, Kyunghee medical center | Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital | Gangdong Kyunghee University Hospital | Kyung Hee East-West Neo Medical Center | Kyung Hee Oriental Medical Center | Kyunghee University | Kyung Hee University College of Medicine & Kyung Hee University Medical Center | Kyung-Hee University East-West Med. Center | Kyung Hee University Gangdong Hospital | KyungHee University Gangdong Hospital | Kyung Hee University Gangdong Hospital of Korea | Kyung Hee university Hosipital at Gangdong | Kyunghee University Hospital | Kyung Hee University Hospital | Kyunghee university hospital A Drug Analytical Laboratory | Kyunghee University Hospital at Gandong | Kyung Hee University Hospital at Gangdong | KyungHee University Hospital at Gangdong | Kyung Hee University Korean Medical Center | Kyunghee University Medical Center | Kyung Hee University Medical Center, Department of Pediatrics, | Kyung Hee University Medical Center Oriental Hospital | Kyung Hee University Medical Hospital | Kyunghee University Oriental Medical Center | Kyung Hee University Oriental Medicine Hospital | School of Medicine, Kyung Hee University | Seong-Gyu Ko | Spine Center, Kyung Hee University Hospital at Gangdong
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2006Last known activity
Oct 10, 2024
Timeline
1940s
- Jan 1, 1949
Kyung Hee University— Founded
Drugs by trial phase (138 distinct, 127 trials)
Phase 4 (60 own, 0 via acquisition)
Phase 3 (38 own, 0 via acquisition)
Phase 2 (22 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Angina, Stable
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Ascites
- Atrial Fibrillation
- Back Pain
- Behcet Syndrome
- Bronchitis
- Cerebral Infarction
- Cerebral Palsy
- Constriction, Pathologic
- Coronary Artery Disease
- Coronary Disease
- Cough
- Crohn Disease
- Cryopyrin-Associated Periodic Syndromes
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Neuropathies
- Dyslipidemias
- Dyspepsia
- Eczema
- Edema
- Encephalitis
- Encephalitis, Japanese
- Endometriosis
- Essential Hypertension
- Gastritis
- Glomerulonephritis
- Glomerulonephritis, IGA
- Heart Diseases
- Hepatitis
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hernia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hypersensitivity
- Hypertension
- Hypotension
- Hypotension, Orthostatic
- Infarction
- Infections
- Intermittent Claudication
- Ischemia
- Kidney Diseases
- Low Back Pain
- Lung Diseases
- Lung Diseases, Obstructive
- Lung Neoplasms
- Macular Degeneration
- Macular Edema
- Mucocutaneous Lymph Node Syndrome
- Myocardial Infarction
- Myocardial Ischemia
- Nausea
- Neck Pain
- Neuralgia
- Nose Diseases
- Obesity
- Osteoarthritis
- Osteoarthritis, Knee
- Overweight
- Parkinson Disease
- Postoperative Nausea and Vomiting
- Postoperative Pain
- Prediabetic State
- Pulmonary Disease, Chronic Obstructive
- Radiculopathy
- Renal Insufficiency, Chronic
- Reperfusion Injury
- Respiratory Tract Diseases
- Respiratory Tract Infections
- Retinal Vein Occlusion
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Sleep Initiation and Maintenance Disorders
- Small Cell Lung Carcinoma
- Spinal Stenosis
- Spondylitis
- Spondylitis, Ankylosing
- ST Elevation Myocardial Infarction
- Stroke
- Uterine Cervical Neoplasms
- Uveitis
- Ventricular Remodeling
- Vomiting
- Wet Macular Degeneration
- Wounds and Injuries
- Xerostomia
Recent trials (50)
- NCT06650644OfficialN/AOct 10, 2024
- NCT06650644Lead sponsorN/AOct 10, 2024
- NCT06650644Sponsor investigatorN/AOct 10, 2024
- NCT06329141CollaboratorPhase 2Jul 1, 2024
- NCT06113497Study chairPhase 4Nov 25, 2023
- NCT06113497Lead sponsorPhase 4Nov 25, 2023
- NCT06113497Reponsible party - principal investigatorPhase 4Nov 25, 2023
- NCT06064864CollaboratorN/AOct 9, 2023
- NCT07038226Lead sponsorN/AOct 2, 2023
- NCT07038226Sponsor investigatorN/AOct 2, 2023
- NCT06287606OfficialPhase 3Aug 29, 2023
- NCT05944627Overall official - principal investigatorPhase 1/Phase 2Jul 6, 2023
- NCT05944627Overall official - principal investigatorPhase 1/Phase 2Jul 6, 2023
- NCT05364580OfficialPhase 3Mar 6, 2023
- NCT05670470Overall official - principal investigatorPhase 3Sep 21, 2022
Details
- Founded
- Seoul, KR Jan 1, 1949
- Last known activity
- Oct 10, 2024